표면 소독제 : 시장 점유율 분석, 업계 동향 및 통계, 성장 예측(2026-2031년)

According to Mordor Intelligence, the surface disinfectant market size is expected to increase from USD 5.60 billion in 2025 to USD 5.90 billion in 2026 and reach USD 7.70 billion by 2031, growing at a CAGR of 5.46% over 2026-2031.

This report is Segmented by Chemical Composition (Quaternary Ammonium Compounds, and More), Form (Liquids, and More), Application (Surface Disinfection, and More), End-User (Hospitals & Clinics, and More), Distribution Channel (Direct Institutional Sales, and More), and Geography (North America, and More). The Market Sizes and Forecasts are Provided in Terms of Value (USD).

Global Surface Disinfectant Market Trends and Insights

Rising Incidence of Hospital-Acquired Infections

Hospitals globally face ongoing pressure to reduce infections associated with central lines, catheters, and surgical sites. These infections impose an annual financial burden of USD 28 to 45 billion on the U.S. healthcare system. In 2024, surveillance data indicated a 9% decline in central-line infections and a 10% reduction in catheter-related infections. However, surgical-site infections following abdominal hysterectomies increased by 8%, highlighting that generalized QAC protocols may fail to address procedure-specific infection vectors. Patients in low- and middle-income countries experience infection risks up to 20 times higher than those in wealthier nations. As a result, peroxide and alcohol blends dominate high-income markets, while hypochlorite solutions maintain cost leadership in other regions. Additionally, Medicare penalizes hospitals in the highest infection quartile by withholding up to 3% of payments, making infection prevention a critical factor in protecting revenue and justifying investments in premium disinfectants. These factors collectively drive the surface disinfectant market's sustained growth trajectory.

Growth in Surgical Procedures & Chronic-Care Admissions

By 2030, global surgical volumes are expected to surpass 400 million annually, driven by aging populations and expanded healthcare access in key markets such as China and India. In the United States, minimally invasive techniques now account for over 60% of elective abdominal procedures. In the Asia-Pacific region, hospital admissions for chronic conditions, including diabetes, cardiovascular, and pulmonary diseases, are increasing by 4-5% annually. This trend is extending hospital stays and driving higher chemistry consumption per bed-day. In 2024, outpatient centers in the United States performed 28 million procedures, up from 23 million in 2020. These facilities are required to comply with the same Joint Commission protocols as inpatient wards, further expanding the market for surface disinfectants.

Toxicity & Environmental Scrutiny of Chlorine & QAC Chemistries

In 2024, the U.S. EPA proposed restrictions on 14 QAC pesticide products due to violations related to aquatic toxicity. At the same time, California introduced requirements for front-label disclosures of QACs, accelerating the transition toward alternatives like hydrogen peroxide and peracetic acid. In 2025, European regulators are set to review benzalkonium and didecyldimethylammonium chloride, with potential EU-wide concentration limits anticipated by 2027. Furthermore, peer-reviewed studies in 2024 identified QAC-resistance genes in hospital wastewater, driving committees to adopt more frequent rotations of chemical formulations.

Other drivers and restraints analyzed in the detailed report include:

1. Stringent Infection-Control Regulations in Emerging Markets
2. Post-Pandemic Hygiene-Budget Normalization at Elevated Baseline
3. Emergence of Disinfectant-Tolerant Microbial Strains

For complete list of drivers and restraints, kindly check the Table Of Contents.

Segment Analysis

Hydrogen peroxide and peracetic acid solutions are expanding at a 7.80% CAGR, the swiftest among actives, and are on track to capture USD 2.55 billion of the surface disinfectant market size by 2031. Alcohols remained the revenue leader in 2025 because they offer quick kill and no rinse, but flammability and surface-drying concerns limit penetration in electronics and food plants. Quaternary ammonium compounds still dominate cost-sensitive geographies because they undercut peroxide prices by 30-50%, although rising regulatory scrutiny is nudging North American and European buyers toward peroxide and alcohol blends.

In 2025, liquid concentrates commanded a 43.2% share of the Surface Disinfectants market, making them the largest formulation segment by market size, thanks to their cost-to-coverage efficiency. Facilities prefer liquids for floor-mopping systems and central dilution stations because dosing precision supports audit compliance. A side benefit is that large packs reduce packaging disposal volumes, aligning with healthcare sustainability pledges and indirectly limiting landfill surcharges. By retaining liquids as the baseline, vendors secure predictable raw-material purchasing, a factor that cushions margin volatility. Sprays and aerosols are projected to grow at an 8.5% CAGR through 2031, making them the fastest-growing formulation segment within the Surface Disinfectants industry.

Geography Analysis

North America retained a 34.7% share of the surface disinfectants market in 2025, with reimbursement rules tying infection-prevention metrics to funding levels, effectively institutionalising demand. Hospital purchasing groups increasingly issue tenders that bundle liquid concentrates, ready-to-use wipes, and electrostatic sprayer fluids under a single contract, an arrangement that favours suppliers offering complete portfolios. The region is also a first mover in adopting hydrogen peroxide vapour decontamination for isolation rooms, thereby increasing the average revenue per disinfected square metre. Suppliers notice that state procurement teams now request carbon-footprint disclosures alongside efficacy data, signalling that environmental metrics may soon influence bid scoring as strongly as price.

Asia-Pacific is projected to deliver an 8.9% CAGR between 2025 and 2030, the fastest regional pace in the Surface Disinfectants market. Government incentives supporting new hospital construction in China, India, and Indonesia are translating into early-stage framework agreements with disinfectant vendors, embedding long-run revenue visibility. Local producers leverage familiarity with fragmented distribution networks to win tenders in secondary cities, yet premium international brands still dominate tertiary-level facilities. Because construction codes now specify built-in disinfection storage and dispensing systems, upfront chemical specifications are being locked in during architectural tendering, a nuance that reorders sales cycles. Incremental demand from pharmaceutical cleanrooms and medical-device factories adds a parallel industrial revenue stream, allowing suppliers to amortise formulation R&D across both end markets.

Europe remains a regulatory bellwether, guiding ingredient restrictions and efficacy testing protocols that often prefigure global norms. Regional emphasis on circular packaging has spurred concentrated refills and cardboard canisters, practices that later migrate to North America once proven viable. Southern and Eastern European hospitals, facing tighter capital budgets, opt for mixed approaches that combine legacy chlorine solutions for non-critical areas with peroxide wipes in intensive care units, demonstrating how cost-tiering strategies shape vendor portfolios. In March 2024, the European Chemicals Agency advanced proposals to reclassify quaternary ammonium compounds, a move that could accelerate product reformulation cycles and spur demand for alternative actives. The continent's variable reimbursement structures, from single-payer to mixed systems, create a patchwork market that rewards suppliers adept at tailoring value propositions by country.

1. 3M
2. BASF
3. Betco Corporation
4. Diversey Holdings Ltd.
5. Ecolab
6. Evonik Industries
7. GOJO Industries Inc.
8. Johnson & Johnson Services, Inc. (Microban 24)
9. Kimberly-Clark Worldwide
10. LANXESS AG
11. Medline Industries
12. Metrex Research
13. Hartmann Group
14. PDI Corporation
15. Procter & Gamble
16. Reckitt Benckiser Group
17. SC Johnson Professional
18. Spartan Chemical Company Inc.
19. STERIS plc (incl. Cantel)
20. The Clorox Company
21. Unilever plc
22. Whiteley Corporation

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

TABLE OF CONTENTS

1 Introduction

• 1.1 Study Assumptions & Market Definition
• 1.2 Scope of the Study

2 Research Methodology

3 Executive Summary

4 Market Landscape

• 4.1 Market Overview
• 4.2 Market Drivers
  • 4.2.1 Rising Incidence of Hospital-Acquired Infections
  • 4.2.2 Growth in Surgical Procedures & Chronic-Care Admissions
  • 4.2.3 Stringent Infection-Control Regulations in Emerging Markets
  • 4.2.4 Post-Pandemic Institutional Hygiene-Budget Normalization at Elevated Baseline
  • 4.2.5 Adoption of IoT-Enabled Smart-Disinfection Compliance Systems
  • 4.2.6 Subscription-Based Chemical-Replenishment Models Gaining Traction
• 4.3 Market Restraints
  • 4.3.1 Toxicity & Environmental Scrutiny of Chlorine & QAC Chemistries
  • 4.3.2 Surface-Compatibility Issues with Sensitive Electronics & Finishes
  • 4.3.3 Tariff Volatility & Raw-Material Supply Disruptions (Ethanol, Qacs)
  • 4.3.4 Emergence of Disinfectant-Tolerant Microbial Strains
• 4.4 Supply-Chain Analysis
• 4.5 Regulatory Landscape
• 4.6 Technological Outlook
• 4.7 Porter's Five Forces Analysis
  • 4.7.1 Bargaining Power of Buyers
  • 4.7.2 Bargaining Power of Suppliers
  • 4.7.3 Threat of New Entrants
  • 4.7.4 Threat of Substitute Products
  • 4.7.5 Intensity of Competitive Rivalry

5 Market Size & Growth Forecasts (Value, USD)

• 5.1 By Chemical Composition
  • 5.1.1 Quaternary Ammonium Compounds
  • 5.1.2 Hypochlorite
  • 5.1.3 Alcohols
  • 5.1.4 Aldehydes
  • 5.1.5 Peroxides (Hydrogen & Peracetic Acid)
  • 5.1.6 Phenolic Compounds
  • 5.1.7 Iodine Compounds
• 5.2 By Form
  • 5.2.1 Liquids (Dilutable & RTU)
  • 5.2.2 Wipes
  • 5.2.3 Sprays & Foams
  • 5.2.4 Tablets & Powdered Concentrates
• 5.3 By Application
  • 5.3.1 Surface Disinfection
  • 5.3.2 Instrument Disinfection
  • 5.3.3 Air & Room Decontamination
  • 5.3.4 Food-Contact Surface Sanitization
• 5.4 By End-User
  • 5.4.1 Hospitals & Clinics
  • 5.4.2 Outpatient & Ambulatory Surgical Centers
  • 5.4.3 Diagnostic Laboratories
  • 5.4.4 Pharmaceutical & Biotechnology Manufacturing
  • 5.4.5 Food & Beverage Processing Facilities
  • 5.4.6 Commercial & Institutional Buildings
  • 5.4.7 Residential / Household
• 5.5 By Distribution Channel
  • 5.5.1 Direct Institutional Sales
  • 5.5.2 Specialty Distributors
  • 5.5.3 Retail (Super/Hypermarkets)
  • 5.5.4 Online & Subscription E-commerce
• 5.6 By Geography
  • 5.6.1 North America
    • 5.6.1.1 United States
    • 5.6.1.2 Canada
    • 5.6.1.3 Mexico
  • 5.6.2 Europe
    • 5.6.2.1 Germany
    • 5.6.2.2 United Kingdom
    • 5.6.2.3 France
    • 5.6.2.4 Italy
    • 5.6.2.5 Spain
    • 5.6.2.6 Rest of Europe
  • 5.6.3 Asia-Pacific
    • 5.6.3.1 China
    • 5.6.3.2 India
    • 5.6.3.3 Japan
    • 5.6.3.4 Australia
    • 5.6.3.5 South Korea
    • 5.6.3.6 Rest of Asia-Pacific
  • 5.6.4 Middle East and Africa
    • 5.6.4.1 GCC
    • 5.6.4.2 South Africa
    • 5.6.4.3 Rest of Middle East and Africa
  • 5.6.5 South America
    • 5.6.5.1 Brazil
    • 5.6.5.2 Argentina
    • 5.6.5.3 Rest of South America

6 Competitive Landscape

• 6.1 Market Concentration
• 6.2 Market Share Analysis
• 6.3 Company Profiles (includes Global level Overview, Market-level Overview, Core Segments, Financials, Strategic Information, Market Rank/Share, Products & Services, Recent Developments)
  • 6.3.1 3M Company
  • 6.3.2 BASF SE
  • 6.3.3 Betco Corporation
  • 6.3.4 Diversey Holdings Ltd.
  • 6.3.5 Ecolab Inc.
  • 6.3.6 Evonik Industries AG
  • 6.3.7 GOJO Industries Inc.
  • 6.3.8 Johnson & Johnson Services, Inc. (Microban 24)
  • 6.3.9 Kimberly-Clark Corporation
  • 6.3.10 LANXESS AG
  • 6.3.11 Medline Industries LP
  • 6.3.12 Metrex Research LLC
  • 6.3.13 Paul Hartmann AG
  • 6.3.14 PDI Corporation
  • 6.3.15 Procter & Gamble
  • 6.3.16 Reckitt Benckiser Group plc
  • 6.3.17 SC Johnson Professional
  • 6.3.18 Spartan Chemical Company Inc.
  • 6.3.19 STERIS plc (incl. Cantel)
  • 6.3.20 The Clorox Company
  • 6.3.21 Unilever plc
  • 6.3.22 Whiteley Corporation

7 Market Opportunities & Future Outlook

• 7.1 White-space & Unmet-Need Assessment